FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

FDA, FBI Sign MOU

09/28/2005

Federal Register Notice: FDA is providing notice of a memorandum of understanding between the FDA and the FBI to establish the gen...

FDA, National Library of Medicine Sign MOU

09/28/2005

Federal Register Notice: FDA is providing notice of a memorandum of understanding between FDA and the National Library of Medicine...

FDA Withdraws 13 NDAs

09/21/2005

Federal Register Notice: FDA is withdrawing approval of 13 NDAs from multiple holders because the application holders have repeate...

Dallas District, SoCRA Plan Trials Workshop

09/21/2005

Federal Register Notice: FDA’s Dallas District, in cooperation with the Society of Clinical Research Associates (SoCRA), will spon...

Panel to Discuss Somerset’s Emsam

09/21/2005

Federal Register Notice: FDA’s Psychopharmacologic Drugs Advisory Committee will meet 10/25, from 8 a.m. to 5 p.m. and 10/26, from...

Public Meeting Postponed Due to Katrina

09/12/2005

Federal Register Notice: FDA is postponing one of a series of public meetings entitled “Vision 2006 — A Conversation With the Amer...

Comments Sought on Device Recall Authority

09/02/2005

Federal Register Notice: FDA is seeking public comment on a proposed collection of information entitled “Medical Device Recall Aut...

Blood Products Panel to Discuss Iron Overload Treatment

09/02/2005

Federal Register Notice: FDA’s Blood Products Advisory Committee will meet 9/29, from 8 a.m. to 5 p.m. at the FDA Conference Room ...

Animal Drug Sponsor Changes to Pharmaq

09/02/2005

Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor for an approved NADA from ...

NADAs, ANADA Withdrawn

08/26/2005

Federal Register Notice: FDA is withdrawing approval of 16 new animal drug applications and one ANADA because the products are no ...